http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105949214-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-08 |
| filingDate | 2016-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105949214-B |
| titleOfInvention | Norcantharidin mono-acid sodium salt derivative and its antitumor application thereof |
| abstract | The present invention provides a kind of Norcantharidin mono-acid sodium salt derivatives, and structural formula is as shown in Equation 7, Active testing proves that the Norcantharidin mono-acid sodium salt derivative 7 that the present invention designs and synthesizes has good inhibitory activity for three kinds of liver cancer, gastric cancer and colon cancer, it is expected to be applied to prepare above-mentioned three kinds of antitumor drugs. |
| priorityDate | 2016-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 52.